GO:0060352 cell adhesion molecule production: Biosynthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060352 (cell adhesion molecule production) is defined as the appearance of a cell adhesion molecule due to biosynthesis or secretion [QuickGO definition].
• Cell adhesion molecules (CAMs) are produced in response to developmental cues, neural activity, and inflammatory signals, and their production is tightly regulated at transcriptional and post-transcriptional levels [2, 7].
• Dysregulated production of CAMs such as CEACAM6 and plexin contributes to cancer progression, viral entry, and neurological disorders [3, 4, 5].
• Inflammatory mediators like uric acid and nanoparticles can stimulate CAM production in endothelial and epithelial cells, linking this process to vascular disease and tissue remodeling [6, 7].
• Experimental models for studying GO:0060352 include knockout, point-mutation, knock-in, and overexpression cell lines, as well as CRISPR library screening [general knowledge].
• EDITGENE provides end-to-end CRISPR services to dissect the genetic control of cell adhesion molecule production in disease-relevant models [general knowledge].
Description
Cell adhesion molecule production (GO:0060352) is a biological process defined as the appearance of a cell adhesion molecule due to biosynthesis or secretion. Cell adhesion molecules (CAMs) are surface or secreted proteins that mediate cell-cell and cell-extracellular matrix interactions, and their production is essential for tissue development, immune surveillance, and neural wiring [2, 5]. The term encompasses both the synthesis of new CAM proteins and their release into the extracellular space, distinguishing it from downstream functions such as adhesion itself. Researchers study GO:0060352 to understand how cells dynamically remodel their adhesive properties in response to physiological and pathological stimuli. For example, neural cell adhesion molecule (NCAM) expression in skeletal muscle is regulated by innervation, demonstrating that CAM production is under tight external control. Similarly, inflammatory cues such as uric acid can trigger the production of adhesion molecules in vascular endothelium, linking this process to atherosclerosis and other inflammatory diseases. The production of CAMs is also exploited by pathogens; CEACAM6 serves as a receptor for influenza A virus, and its production levels influence viral entry. Thus, GO:0060352 sits at the crossroads of development, immunity, and disease, making it a compelling target for basic and translational research.
cell adhesion molecule production At A Glance
| GO ID | GO:0060352 |
|---|---|
| GO term | cell adhesion molecule production |
| Ontology | biological_process |
| Synonym | None |
| Definition | The appearance of a cell adhesion molecule due to biosynthesis or secretion. |
| Major function | Production of proteins that mediate cell-cell and cell-matrix adhesion. |
| Related processes | Protein biosynthesis, secretion, cell adhesion, immune response. |
| Disease relevance | Cancer, viral infection, neurodevelopmental disorders, inflammation. |
What Is GO:0060352?
According to the Gene Ontology, GO:0060352 (cell adhesion molecule production) is the biological process that results in the appearance of a cell adhesion molecule due to biosynthesis or secretion. This includes the synthesis of CAM proteins through gene expression and their subsequent secretion or surface presentation. The term does not cover the adhesive function itself, but rather the upstream events that make a CAM available.
Why Is cell adhesion molecule production Important in Cell Biology?
Understanding cell adhesion molecule production is critical because CAMs are central to tissue architecture, immune cell trafficking, and neuronal connectivity. Aberrant production of CAMs is associated with cancer metastasis, viral entry, and chronic inflammatory diseases [3, 4, 7]. For instance, CEACAM6 is overproduced in various cancers and serves as a receptor for influenza A virus, making its production a target for therapeutic intervention [3, 4]. In the nervous system, plexin production is required for axon guidance and neural network formation. Moreover, environmental factors such as silver nanoparticles can alter CAM expression and basement membrane integrity, highlighting the sensitivity of this process to external insults. Therefore, studying GO:0060352 provides insights into fundamental cell biology and offers opportunities for drug discovery and diagnostics.
• Cell adhesion molecule production is essential for embryonic development and tissue morphogenesis [2, 5].
• Dysregulated CAM production contributes to cancer progression and metastasis.
• CAMs such as CEACAM6 act as viral receptors, linking production levels to infection susceptibility.
• Inflammatory mediators like uric acid stimulate CAM production in endothelium, promoting vascular disease.
• Neural CAM production is regulated by innervation, affecting muscle regeneration and neuromuscular junction stability.
• Plexin production is critical for axon guidance and neural circuit formation.
• Silver nanoparticles can disrupt CAM expression and basement membrane integrity in epithelial tissues.
• Ligand binding to LFA-3 induces IL-1 production, showing crosstalk between adhesion molecules and cytokine networks.
• CAM production is a potential biomarker for antibody-drug conjugate efficacy.
• Targeting CAM production pathways may yield new therapies for inflammatory and infectious diseases [1, 3].
What Happens During cell adhesion molecule production?
Transcriptional activation of CAM genes
In simple terms: The cell receives a signal to start making more adhesion molecules.
The production of cell adhesion molecules begins with transcriptional activation of genes encoding CAMs. External stimuli such as neural activity, inflammatory cytokines, or pathogen-associated molecules trigger signaling cascades that activate transcription factors. For example, uric acid promotes chemokine and adhesion molecule production in vascular endothelium via nuclear factor-kappa B signaling. Similarly, nerve-dependent regulation of neural cell adhesion molecule expression in skeletal muscle demonstrates that innervation controls NCAM transcription. This step ensures that CAM production is responsive to environmental cues.
mRNA processing and translation
In simple terms: The genetic instructions are copied and translated into proteins.
Following transcription, CAM mRNAs are processed, exported to the cytoplasm, and translated into proteins. The efficiency of translation can be modulated by microRNAs and RNA-binding proteins, although specific mechanisms for CAMs are not fully detailed in the provided literature. The net result is the synthesis of CAM polypeptides that are either inserted into the plasma membrane or destined for secretion.
Post-translational modifications and trafficking
In simple terms: The new proteins are modified and sent to the cell surface or outside the cell.
Newly synthesized CAMs undergo post-translational modifications such as glycosylation, which can affect their stability and binding properties. For instance, CEACAM6 is a heavily glycosylated protein that serves as a receptor for influenza A virus. Proper folding and trafficking are essential for CAMs to reach the cell surface or be secreted. Disruption of these processes can lead to intracellular retention and impaired function.
Secretion or surface presentation
In simple terms: The finished adhesion molecules appear on the cell surface or are released.
The final step in cell adhesion molecule production is the appearance of the CAM at its functional destination. This may involve secretion into the extracellular space or insertion into the plasma membrane. For example, LFA-3 (CD58) is a cell surface CAM that, upon ligand binding, induces IL-1 production by human thymic epithelial cells. The appearance of the CAM is the defining event of GO:0060352.
Regulation by external signals
In simple terms: Outside signals can turn production up or down.
CAM production is dynamically regulated by external signals. Silver nanoparticles alter epithelial basement membrane integrity and cell adhesion molecule expression, indicating that xenobiotic exposure can modulate this process. Similarly, Limosilactobacillus reuteri HY7503 and its cellular proteins alleviate endothelial dysfunction by regulating cell adhesion molecule levels. These examples highlight the sensitivity of GO:0060352 to environmental and microbial factors.
Key Genes Involved in GO:0060352 cell adhesion molecule production
The following genes and proteins are experimentally linked to cell adhesion molecule production (GO:0060352) or its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NCAM1 | Neural cell adhesion molecule; mediates cell-cell adhesion in nervous system and muscle | Innervation-dependent regulation in skeletal muscle |
| CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6; receptor for influenza A virus | Viral entry and antibody-drug conjugate targeting [3, 4] |
| PLXNA1 | Plexin A1; semaphorin receptor involved in axon guidance | Neuron network formation |
| CD58 | LFA-3; cell adhesion molecule on thymic epithelial cells | Induces IL-1 production upon ligand binding |
| ICAM1 | Intercellular adhesion molecule 1; endothelial adhesion molecule | Uric acid-induced production in vascular endothelium |
| VCAM1 | Vascular cell adhesion molecule 1; mediates leukocyte adhesion | Regulated by inflammatory signals |
| SELE | E-selectin; endothelial adhesion molecule | Involved in endothelial dysfunction |
| SELL | L-selectin; leukocyte adhesion molecule | Potential target in inflammation |
| ITGB1 | Integrin beta 1; cell-matrix adhesion | Modulated by silver nanoparticles |
| ITGA5 | Integrin alpha 5; fibronectin receptor | Epithelial basement membrane integrity |
| CDH1 | E-cadherin; epithelial cell-cell adhesion | Affected by nanoparticle exposure |
| CDH2 | N-cadherin; neural and mesenchymal adhesion | Neural development |
| NCAM2 | Neural cell adhesion molecule 2 | Neural network formation |
| ALCAM | Activated leukocyte cell adhesion molecule | Immune cell trafficking |
| PECAM1 | Platelet endothelial cell adhesion molecule | Endothelial function |
| JAM2 | Junctional adhesion molecule 2 | Tight junction regulation |
| CLDN1 | Claudin 1; tight junction protein | Epithelial barrier integrity |
How Is cell adhesion molecule production Regulated?
Cell adhesion molecule production is regulated at multiple levels. Transcriptional regulation by NF-κB is a key mechanism, as uric acid promotes chemokine and adhesion molecule production in vascular endothelium via nuclear factor-kappa B signaling. Neural activity regulates NCAM expression in skeletal muscle, demonstrating activity-dependent transcriptional control. Post-transcriptional mechanisms, including mRNA stability and translation efficiency, also contribute. Additionally, external factors such as silver nanoparticles can alter CAM expression, suggesting that environmental stressors modulate this process. Microbial components, such as those from Limosilactobacillus reuteri, can regulate cell adhesion molecule levels in endothelial cells. These regulatory layers ensure that CAM production is appropriately tuned to physiological demands.
cell adhesion molecule production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CEACAM6 | Cancer, influenza A virus entry | Knockout and overexpression in cancer cell lines; viral infection assays [3, 4] |
| PLXNA1 | Neurodevelopmental disorders | Knockout in neuronal cultures; axon guidance assays |
| ICAM1 | Atherosclerosis, inflammation | Endothelial cells treated with uric acid; KO and overexpression |
| NCAM1 | Muscle atrophy, neuromuscular junction disorders | Denervation models; KO mice |
| CD58 | Thymic epithelial cell function, immune regulation | KO in thymic epithelial cells; IL-1 production assays |
Cancer and metastasis
Overproduction of cell adhesion molecules such as CEACAM6 is observed in various cancers and contributes to metastasis and resistance to therapy. CEACAM6-targeting antibody-drug conjugates exploit its high production for targeted therapy, and normalized internalization predicts their potency. Thus, understanding the regulation of CEACAM6 production is critical for optimizing these therapeutics.
Viral infection
CEACAM6 acts as a protein receptor for influenza A virus, and its production levels on host cells influence viral entry and pathogenesis. Modulating CAM production may therefore affect susceptibility to viral infections.
Inflammatory and vascular diseases
Uric acid promotes the production of chemokines and adhesion molecules in vascular endothelium via NF-κB, linking CAM production to atherosclerosis and other inflammatory conditions. Similarly, endothelial dysfunction can be alleviated by Limosilactobacillus reuteri HY7503, which regulates cell adhesion molecule levels.
Neurodevelopmental disorders
Plexin, a cell adhesion molecule, is required for neuron network formation, and its production is essential for axon guidance. Dysregulation of NCAM production in skeletal muscle is associated with neuromuscular disorders.
From cell adhesion molecule production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate cell adhesion molecule production? | Knockout cell line (e.g., CRISPR-Cas9) followed by Western blot or ELISA for CAMs |
| Does a specific point mutation in gene X affect CAM production? | Point-mutation knock-in cell line generated by CRISPR |
| Does overexpression of gene X increase CAM production? | Overexpression cell line (lentiviral or CRISPR activation) |
| Where is the CAM produced and where does it localize? | Tagged knock-in (e.g., GFP or HA tag) for imaging |
| Which genes are essential for CAM production? | Genome-wide CRISPR library screening with CAM production as readout |
| How does a drug affect CAM production? | Pharmacological perturbation in wild-type and KO cells |
How to Study the cell adhesion molecule production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | mRNA levels of CAM genes | Transcriptional profiling of CAM production |
| Proteomics | Protein abundance of CAMs | Detection of secreted or surface CAMs |
| Flow cytometry | Surface CAM protein levels | Quantification of CAM production in cell populations |
| Immunofluorescence | Subcellular localization of CAMs | Trafficking and surface presentation |
| ELISA | Secreted CAM concentrations | Measuring secretion of soluble CAMs |
| Western blot | Total CAM protein levels | Validation of knockout or overexpression |
| CRISPR screening | Genes required for CAM production | Functional genomics [general knowledge] |
| Viral entry assay | CEACAM6-dependent influenza A entry | Host-pathogen interaction |
Transcriptomic analysis (RNA-seq)
RNA sequencing can quantify mRNA levels of cell adhesion molecule genes under different conditions, providing a global view of transcriptional regulation of GO:0060352. This method is useful for identifying pathways that drive CAM production, such as NF-κB signaling.
Proteomic and secretomic profiling
Mass spectrometry-based proteomics can detect CAM proteins in cell lysates or conditioned media, directly measuring the appearance of CAMs due to biosynthesis or secretion. This is particularly relevant for secreted CAMs or those shed from the cell surface.
Flow cytometry and immunofluorescence
Flow cytometry using antibodies against surface CAMs (e.g., CEACAM6, ICAM1) allows quantification of CAM production at the single-cell level. Immunofluorescence can visualize subcellular localization and trafficking [3, 8].
Functional assays
Adhesion assays, viral entry assays, and immune cell binding assays can measure the functional consequences of altered CAM production. For example, influenza A virus entry can be assessed in cells with modulated CEACAM6 production.
How CRISPR Can Be Used to Study GO:0060352 cell adhesion molecule production
Knockout
CRISPR-Cas9 knockout of genes encoding cell adhesion molecules or their regulators can abolish CAM production, enabling loss-of-function studies. For example, knocking out CEACAM6 in cancer cell lines can reduce influenza A virus entry and antibody-drug conjugate efficacy [3, 4]. Knockout models are essential to establish causality.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to dissect functional domains of CAMs. For instance, mutating glycosylation sites on CEACAM6 may affect its receptor function for influenza A virus. Point-mutation knock-in cell lines provide precise genetic models.
Knock-in
Knock-in of tagged versions of CAMs (e.g., GFP, HA) allows real-time tracking of CAM production, trafficking, and secretion. This approach is valuable for understanding the dynamics of GO:0060352 in live cells.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can increase CAM production, mimicking pathological overexpression seen in cancer. Overexpression models are useful for testing therapeutic antibodies or antibody-drug conjugates targeting CAMs like CEACAM6.
How EDITGENE Supports cell adhesion molecule production Research
Researchers studying cell adhesion molecule production-related genes often need to determine whether a candidate gene is causally involved in the appearance of CAMs or is merely correlated. This requires precise genetic manipulation, which is best achieved through CRISPR-based models. EDITGENE provides a comprehensive suite of services to generate knockout, point-mutation, knock-in, and overexpression cell lines, as well as CRISPR library screening and bioinformatics support, enabling rigorous investigation of GO:0060352.
Contact EDITGENE today to design your custom CRISPR model for cell adhesion molecule production research.
Frequently Asked Questions About cell adhesion molecule production
What is GO:0060352?
GO:0060352 is the Gene Ontology term for cell adhesion molecule production, defined as the appearance of a cell adhesion molecule due to biosynthesis or secretion.
What genes are involved in cell adhesion molecule production?
Genes such as NCAM1, CEACAM6, PLXNA1, CD58, ICAM1, and VCAM1 are involved in the production of cell adhesion molecules [2, 3, 5, 7, 8].
How is cell adhesion molecule production regulated?
It is regulated transcriptionally by factors like NF-κB and activity-dependent signals, as well as post-transcriptionally [2, 7].
What diseases are associated with abnormal cell adhesion molecule production?
Cancer, viral infections, inflammatory diseases, and neurodevelopmental disorders are linked to dysregulated CAM production [3, 4, 5, 7].
What methods are used to study cell adhesion molecule production?
RNA-seq, proteomics, flow cytometry, immunofluorescence, and functional assays are commonly used [3, 7, 8].
Can CRISPR be used to study cell adhesion molecule production?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the genetic control of CAM production.
What is the role of CEACAM6 in cell adhesion molecule production?
CEACAM6 is a cell adhesion molecule that serves as a receptor for influenza A virus and is targeted by antibody-drug conjugates [3, 4].
How does uric acid affect cell adhesion molecule production?
Uric acid promotes chemokine and adhesion molecule production in vascular endothelium via NF-κB signaling.
What is the connection between NCAM and muscle?
Nerve-dependent regulation of NCAM expression in skeletal muscle indicates that innervation controls CAM production.
What services does EDITGENE offer for studying cell adhesion molecule production?
EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services.
Conclusion
Cell adhesion molecule production (GO:0060352) is a fundamental biological process that governs the availability of CAMs for cell-cell and cell-matrix interactions. Its dysregulation is implicated in cancer, viral infection, inflammation, and neurological disorders. Understanding the genetic and environmental factors that control CAM production is essential for developing targeted therapies. With advanced CRISPR tools and EDITGENE's comprehensive services, researchers can precisely manipulate and study this process to uncover new therapeutic opportunities.
References
- 1. Jeon H et al.. 2024. Limosilactobacillus reuteri HY7503 and Its Cellular Proteins Alleviate Endothelial Dysfunction by Increasing Nitric Oxide Production and Regulating Cell Adhesion Molecule Levels.. Int J Mol Sci 25(20) PMID: 39457107
- 2. Moore SE et al.. 1986. Nerve dependent regulation of neural cell adhesion molecule expression in skeletal muscle.. Neuroscience 18(2):499-505 PMID: 3016602
- 3. Rahman SK et al.. 2021. The Immunomodulatory CEA Cell Adhesion Molecule 6 (CEACAM6/CD66c) Is a Protein Receptor for the Influenza a Virus.. Viruses 13(5) PMID: 33919410
- 4. Lim JY et al.. 2026. Normalized internalization predicts potency of carcinoembryonic antigen-related cell adhesion molecule 6-targeting antibody-drug conjugates.. J Control Release 396:115106 PMID: 42309467
- 5. Fujisawa H et al.. 1997. Function of a cell adhesion molecule, plexin, in neuron network formation.. Dev Neurosci 19(1):101-5 PMID: 9078440
- 6. Martin ME et al.. 2019. Silver nanoparticles alter epithelial basement membrane integrity, cell adhesion molecule expression, and TGF-β1 secretion.. Nanomedicine 21:102070 PMID: 31351238
- 7. Liang WY et al.. 2015. Uric acid promotes chemokine and adhesion molecule production in vascular endothelium via nuclear factor-kappa B signaling.. Nutr Metab Cardiovasc Dis 25(2):187-94 PMID: 25315669
- 8. Le PT et al.. 1990. Ligand binding to the LFA-3 cell adhesion molecule induces IL-1 production by human thymic epithelial cells.. J Immunol 144(12):4541-7 PMID: 1693636
